Luxturna gene therapy
Credit: OHSU News
Two syringes with the gene therapy treatment Luxturna lie on a table in the surgery suite during Caspian Soto's surgery. Soto, 4, is among the first patients in Oregon to receive a gene therapy approved for inherited vision loss, September 17, 2018 at OHSU Casey Eye Institute. (OHSU/Kristyna Wentz-Graff)